Skip to main content
Table of Contents
Print

When Should Cannabis Be Taken Relative to Therapy SessionsĀ forĀ Depression?Ā 

Author: Dr. Clarissa Morton, PharmD

The question of cannabis timing in therapy is important for patients using cannabis alongside psychological treatment for depression. Some individuals find that taking cannabis before therapy reduces anxiety and improves openness, while others prefer to use it afterwards to process emotions more calmly. The right timing often depends on individual response and therapeutic goals. 

Clinicians may recommend aligning cannabis use with session scheduling to maximise benefits while avoiding impairment. For example, a small dose before therapy might help with therapy preparation, while post-session use may assist with relaxation and integration of insights. 

How Timing Shapes Cannabis and Therapy Outcomes 

The effectiveness of cannabis timing in therapy depends on when it is taken relative to treatment sessions. Below are the main considerations. 

Session Scheduling 

Adjusting cannabis use around session scheduling can help patients either engage more deeply during therapy or unwind after difficult discussions. 

Symptom Management 

Using cannabis strategically can support symptom management, helping patients reduce anxiety, sadness or tension during critical moments of recovery. 

Therapy Preparation 

Some patients use cannabis for therapy preparation, finding it eases resistance and allows them to approach sessions with greater emotional openness. 

In summary, cannabis timing in therapy should be tailored to each patient’s needs. Whether before, during or after sessions, professional guidance ensures cannabis enhances rather than hinders therapeutic progress. 

For advice on integrating cannabis use with therapy for depression, visit providers likeĀ LeafEaseĀ for personalised consultations.Ā 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical CannabisĀ and Depression.

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.Ā 

Categories